Public Sector Anchor Bilthoven’s established UNICEF deliveries and WHO-aligned polio eradication support create a solid base to pursue additional global vaccine procurement contracts and government tenders.

EU Pandemic Opportunity Recent European Commission selection under its pandemic preparedness program indicates public-sector demand for vaccine manufacturing capacity, offering potential multi-year manufacturing and supply agreements.

Strategic Partnerships The 2024 Bharat Biotech collaboration demonstrates a willingness to co-produce and secure supply; leverage the Cyrus Poonawalla Group network to pursue similar co-manufacturing or capacity-sharing deals with other large players.

Portfolio Upside A broad IPV, DT-IPV and BCG product slate positions Bilthoven to offer fill-finish and contract manufacturing services to international immunization programs and cancer-immunotherapy supply chains.

Global Expansion With a Netherlands base and UNICEF/UN agency channels, there are clear paths to expand sales through international tenders, new country partnerships and regional health initiatives in Europe and beyond.